33488 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) (OMB Control 

No. 0920–0612, Exp. 8/31/2022)— 

Extension—National Center for Chronic 

Disease and Public Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The WISEWOMAN program, 

sponsored by the CDC, provides services 

to low income, uninsured, or 

underinsured women aged 40–64. The 

WISEWOMAN program is designed to 

prevent, detect, and control 

hypertension and other cardiovascular 

disease (CVD) risk factors through 

healthy behavior support services which 

are tailored for individual and group 

behavior change. The WISEWOMAN 

program provides services to women 

who are jointly enrolled in the National 

Breast and Cervical Cancer Early 

Detection Program (NBCCEDP), which is 

also administered by CDC. 

The WISEWOMAN program is 

administered by state health 

departments and tribal programs. In 

2018, a new five-year cooperative 

agreement was awarded under Funding 

Opportunity Announcement DP18– 

1816, subject to the availability of funds. 

CDC collects two types of information 

from WISEWOMAN awardees, which is 

submitted in an electronic data file to 

CDC twice per year. The Minimum Data 

Elements (MDE) file contains data using 

a unique identifier with client-level 

information about CVD risk factors and 

types of healthy behavior support 

services for participants served by the 

program. The estimated burden per 

response for the MDE file is 24 hours. 

The Annual Progress Report provides a 

narrative summary of each awardee’s 

objectives and the activities undertaken 

to meet program goals. The estimated 

burden per response is 16 hours. 

There are no changes to the 

information collected. CDC will 

continue to use the information 

collected from WISEWOMAN awardees 

to support program monitoring and 

improvement activities, evaluation, and 

assessment of program outcomes. The 

overall program evaluation helps to 

demonstrate program accomplishments 

and strengthen the evidence for strategy 

implementation for improved 

engagement of underserved populations. 

It can also determine whether the 

identified strategies and associated 

activities can be implemented at various 

levels within a state or tribal 

organization. Evaluation is also 

designed to demonstrate how 

WISEWOMAN can obtain 

cardiovascular disease health outcome 

data on at-risk populations, promote 

public education about CVD risk-factors, 

and improve the availability of healthy 

behavior support services for underserved women. 

CDC requests a two-year Extension of 

this data collection. The total estimated 

annual burden hours are 2,240. 

Participation in this information 

collection is required as a condition of 

cooperative agreement funding. There 

are no costs to respondents other than 

their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Aervage 

burden per 

response 

(in hrs.) 

Total burden 

(in hrs.) 

WISEWOMAN Awardees .................. Screening and Assessment and 

Lifestyle Program MDEs.

35 2 24 1,680 

Annual Progress Report ................... 35 1 16 560 

Total ........................................... ........................................................... ........................ ........................ ........................ 2,240 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–11772 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22FS; Docket No. CDC–2022– 

0071] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Artificial Stone 

Countertops: Exposures, Controls, 

Surveillance, & Translation. The 

purpose of the proposed data collection 

is to conduct a survey with artificial 

stone countertop fabrication facilities to 

better understand, work practices and 

controls related to respirable crystalline 

silica, barriers or facilitators to 

implementation of medical and 

exposure monitoring requirements, and 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33489 

to identify areas for potential 

intervention, as well as countertop 

fabrication facilities willing to 

participate in future NIOSH exposure 

and health research. 

DATES: CDC must receive written 

comments on or before August 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0071 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Artificial Stone Countertops: 

Exposures, Controls, Surveillance, & 

Translation—New—National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

As a recently introduced technology 

in the United States, the Artificial Stone 

(AS) Countertop industry is not well 

defined; the obligation to monitor 

workers’ health might not be known, 

considered, or understood; and 

education on potential hazards and 

health risks related to respirable 

crystalline silica (RCS) is limited. 

Exposure is associated with the 

development of silicosis, an irreversible, 

sometimes fatal, but preventable lung 

disease. Twenty-four cases of silicosis, 

including two deaths, have been 

reported among AS fabrication workers 

in the United States. The anticipated 

impacts of this project are increased 

understanding of industry scale, 

practices, and medical monitoring, and 

increased collaboration and 

communication to inform the AS 

countertop industry of industry hazards, 

methods to mitigate exposure, and 

improvement of medical surveillance. 

Understanding how or if current RCS 

recommendations and regulations are 

used by various AS countertop 

fabrication facilities will identify 

approaches for improved intervention. 

The purpose of the proposed 

collection is to conduct a survey with 

AS countertop fabrication facilities to 

better understand (1) work practices and 

controls related to respirable crystalline 

silica, (2) barriers or facilitators to 

implementation of medical and 

exposure monitoring requirements, (3) 

identify areas for potential intervention, 

and (4) identify countertop fabrication 

facilities willing to participate in future 

NIOSH exposure and health research. 

The estimate of burden hours is based 

on an internal pilot test of the survey 

instrument. In the internal pilot test, 10 

simulated interviews were conducted 

and the average time for reviewing 

instructions, gathering mock 

information, and completing the survey 

was between 10–30 minutes. For the 

purposes of estimating burden hours, 

the median time to complete the survey 

is used. There are approximately 8,694 

countertop fabrication establishments in 

the United States. There are screening 

questions at the beginning of the survey 

so all respondents may not actually 

participate. An estimated 8,600 

respondents are anticipated to 

participate in the survey. CDC requests 

approval for an estimated 2,150 annual 

burden hours. 

There are no costs to respondents 

other than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

AS Countertop Facility Managers/ 

Owners.

Survey .............................................. 8,600 1 15/60 2,150 

Total ........................................... ........................................................... ........................ ........................ ........................ 2,150 


jspears on DSK121TN23PROD with NOTICES1
33490 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–11770 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22FT; Docket No. CDC–2022– 

0073] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Enhanced 

surveillance of respiratory illness among 

people experiencing homelessness in 

Anchorage, Alaska. This project will 

entail collecting nasopharyngeal swabs 

from people experiencing respiratory 

symptoms who are accessing homeless 

services at congregate and noncongregate shelters in Anchorage, 

Alaska. 

DATES: CDC must receive written 

comments on or before August 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0073 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking 

portal (www.regulations.gov) or by U.S. 

mail to the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Enhanced surveillance of Respiratory 

Illness Among People Experiencing 

Homelessness in Anchorage, Alaska— 

New—National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

People experiencing homelessness are 

at risk for respiratory infectious 

diseases. This project involves 

enhanced surveillance for respiratory 

viruses in congregate and noncongregate homeless shelters to provide 

evidence to improve public health for 

people who are experiencing 

homelessness in Anchorage, Alaska. 

The project team will collect an upper 

respiratory specimen (e.g. 

nasopharyngeal swab) from people 

experiencing respiratory symptoms who 

are accessing shelters. The project team 

will complete a short symptom 

questionnaire with the participant and 

then conduct a medical record review to 

ascertain the clinical course of infection. 

Swabs will be tested for multiple viral 

pathogens to estimate the burden of 

pathogen-specific respiratory infections 

among people experiencing 

homelessness. 

CDC requests OMB approval for an 

estimated 500 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Persons with Respiratory Symptoms 

Experiencing Homelessness.

Enrollment in Symptom Screening .. 1,000 1 30/60 500 

Total ........................................... ........................................................... ........................ ........................ ........................ 500 


jspears on DSK121TN23PROD with NOTICES1